Literature DB >> 19083147

Assessment of blood-products use as predictor of pulmonary complications and surgical-site infection after hepatectomy for hepatocellular carcinoma.

Hiroaki Shiba1, Yuji Ishii, Yuichi Ishida, Shigeki Wakiyama, Taro Sakamoto, Ryusuke Ito, Takeshi Gocho, Tadashi Uwagawa, Shoichi Hirohara, Yoshiaki Kita, Takeyuki Misawa, Katsuhiko Yanaga.   

Abstract

BACKGROUND: In perioperative management after hepatectomy, some patients require fresh frozen plasma (FFP) to treat coagulopathy associated with blood loss. However, several studies have suggested a correlation between blood products and pulmonary complications or surgical-site infection (SSI).
METHODS: The subjects were 99 patients who underwent hepatectomy for hepatocellular carcinoma without plasma exchange for postoperative liver failure in the Department of Surgery, Jikei University Hospital, between January 2000 and December 2006. We investigated the association of 16 factors including age; gender; preoperative ICG(R15); type of resection; concomitant resection of other digestive organs; duration of operation; blood loss; hepatitis virus status; postoperative minimum platelet count, maximum serum total bilirubin (max T-Bil), minimum serum albumin, or minimum prothrombin time; and the dose of red-blood-cell concentration (RC), FFP, platelet concentration, or albumin given in relation to postoperative pulmonary complications and SSI.
RESULTS: In univariate analysis, pulmonary complications were correlated with gender (P = 0.012), max T-Bil (P = 0.043), dose of RC given (P = 0.007), dose of FFP given (P < 0.001), and dose of albumin given (P < 0.001). In multivariate analysis, pulmonary complications were correlated with FFP given (P = 0.031) and albumin given (P = 0.020), while the incidence of SSI was not correlated with any factors.
CONCLUSION: Excessive FFP and albumin administration may cause pulmonary complications after hepatectomy.

Entities:  

Mesh:

Year:  2008        PMID: 19083147     DOI: 10.1007/s00534-008-0006-1

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  6 in total

Review 1.  Management of post-hepatectomy complications.

Authors:  Shan Jin; Quan Fu; Gerile Wuyun; Tu Wuyun
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

2.  Clinical prediction score for superficial surgical site infections: Real-life data from a retrospective single-centre analysis of 812 hepatectomies.

Authors:  Juwei Shen; Zuowei Ni; Yigang Qian; Bei Wang; Shusen Zheng
Journal:  Int Wound J       Date:  2019-10-23       Impact factor: 3.315

3.  Gender differences in risk of bloodstream and surgical site infections.

Authors:  Bevin Cohen; Yoon Jeong Choi; Sandra Hyman; E Yoko Furuya; Matthew Neidell; Elaine Larson
Journal:  J Gen Intern Med       Date:  2013-04-19       Impact factor: 5.128

4.  Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection.

Authors:  Hiroaki Shiba; Yuichi Ishida; Shigeki Wakiyama; Tomonori Iida; Michinori Matsumoto; Taro Sakamoto; Ryusuke Ito; Takeshi Gocho; Kenei Furukawa; Yuki Fujiwara; Shoichi Hirohara; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  J Gastrointest Surg       Date:  2009-07-07       Impact factor: 3.452

5.  Intraoperative Transfusion of Fresh Frozen Plasma Predicts Morbidity Following Partial Liver Resection for Hepatocellular Carcinoma.

Authors:  Jan Bednarsch; Zoltan Czigany; Isabella Lurje; Christian Trautwein; Tom Lüdde; Pavel Strnad; Nadine Therese Gaisa; Alexandra Barabasch; Philipp Bruners; Tom Ulmer; Sven Arke Lang; Ulf Peter Neumann; Georg Lurje
Journal:  J Gastrointest Surg       Date:  2020-06-03       Impact factor: 3.452

6.  Incidence and Risk Factors for Organ/Space Infection after Radiofrequency-Assisted Hepatectomy or Ablation of Liver Tumors in a Single Center: More than Meets the Eye.

Authors:  Ioannis Karavokyros; Stamatios Orfanos; Anastasios Angelou; Antonia Meropouli; Dimitrios Schizas; John Griniatsos; Emmanouil Pikoulis
Journal:  Front Surg       Date:  2017-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.